ReviewFrontiers in immunology2025

Advances in PD-1/PD-L1 pathway inhibitors in the treatment of thyroid cancer: mechanisms and clinical therapeutic perspectives.

Xizi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.